Showing results (71-80 of 86) with videos related to
Sort By:
Pageof 9
Hepatology (Baltimore, Md.)|December 25, 2009
Protective effect of human leukocyte antigen B27 in hepatitis C virus infection requires the presence of a genotype-specific immunodominant CD8+ T-cell epitopeChristoph Neumann-Haefelin, Jörg Timm, Julia Schmidt, et al.Nature|December 8, 2022
Autoimmunity-associated T cell receptors recognize HLA-B*27-bound peptidesXinbo Yang, Lee I Garner, Ivan V Zvyagin, et al.Rheumatology (Oxford, England)|June 28, 2013
The arthritis-associated HLA-B*27:05 allele forms more cell surface B27 dimer and free heavy chain ligands for KIR3DL2 than HLA-B*27:09Alberto Cauli, Jacqueline Shaw, Joanna Giles, et al.Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing propertiesEva Billerbeck, Yu-Hoi Kang, Lucy Walker, et al.Nature Communications|September 22, 2020
Single-cell sequencing reveals clonal expansions of pro-inflammatory synovial CD8 T cells expressing tissue-homing receptors in psoriatic arthritisFrank Penkava, Martin Del Castillo Velasco-Herrera, Matthew D Young, et al.Cell Genomics|June 30, 2023
Comprehensive epigenomic profiling reveals the extent of disease-specific chromatin states and informs target discovery in ankylosing spondylitisAndrew C Brown, Carla J Cohen, Olga Mielczarek, et al.Biorxiv : the Preprint Server for Biology|January 27, 2025
Inflammatory disease microbiomes share a functional pathogenicity predicted by C-reactive proteinGraham J Britton, Ilaria Mogno, Alice Chen-Liaw, et al.JCI Insight|July 18, 2024
Mucosal signatures of pathogenic T cells in HLA-B*27+ anterior uveitis and axial spondyloarthritisMichael A Paley, Xinbo Yang, Lynn M Hassman, et al.The Journal of Experimental Medicine|July 28, 2017
A biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosisTobias Schwerd, Stephen R F Twigg, Dominik Aschenbrenner, et al.Nature Genetics|June 30, 2019
A genetics-led approach defines the drug target landscape of 30 immune-related traitsHai Fang, , Hans De Wolf, et al.Pageof 9